CIK 0000014272
- Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 220790350
- Phone
- +1 609-252-4621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $677,826
- in 3 filings
Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-10 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise · Market Share Units | −7,423 | 14,848 | ||
| 2022-03-10 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise · Market Share Units | −7,824 | 23,475 | ||
| 2022-03-10 | VESSEY RUPERT EVP, Research & Early Dev. | Grant or award · Market Share Units | +28,589 | 28,589 | ||
| 2022-03-10 | VESSEY RUPERT EVP, Research & Early Dev. | Grant or award · Performance Shares | +42,884 | 42,884 | ||
| 2022-03-10 | Mily Elizabeth EVP, Strategy & BD | Option exercise | +4,005 | 8,246 | ||
| 2022-03-10 | Mily Elizabeth EVP, Strategy & BD | Other acquisition | +449 | 8,695 | ||
| 2022-03-10 | Mily Elizabeth EVP, Strategy & BD | Shares withheld for taxes | −1,875 | $68.42 | $128K | 6,820 |
| 2022-03-10 | Mily Elizabeth EVP, Strategy & BD | Option exercise · Market Share Units | −4,005 | 12,017 | ||
| 2022-03-10 | Mily Elizabeth EVP, Strategy & BD | Grant or award · Market Share Units | +14,634 | 14,634 | ||
| 2022-03-10 | Mily Elizabeth EVP, Strategy & BD | Grant or award · Performance Shares | +21,952 | 21,952 | ||
| 2022-03-01 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise | +23,350 | 79,587 | ||
| 2022-03-01 | VESSEY RUPERT EVP, Research & Early Dev. | Shares withheld for taxes | −10,303 | $68.63 | $707K | 69,284 |
| 2022-03-01 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise · Restricted Stock Units | −23,350 | 0 | ||
| 2022-03-01 | Elkins David V EVP, Chief Financial Officer | Option exercise | +24,577 | 132,034 | ||
| 2022-03-01 | Elkins David V EVP, Chief Financial Officer | Shares withheld for taxes | −10,381 | $68.63 | $712K | 121,653 |
| 2022-03-01 | Elkins David V EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −24,577 | 0 | ||
| 2022-02-24 | Caforio Giovanni Board Chair and CEO | Sale | −30,000 | $67.00 | $2.0M | 453,455.33 |
| 2022-02-04 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise | +3,593 | 57,549 | ||
| 2022-02-04 | VESSEY RUPERT EVP, Research & Early Dev. | Shares withheld for taxes | −1,312 | $64.99 | $85K | 56,237 |
| 2022-02-04 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise · Restricted Stock Units | −3,593 | 0 |
Page 65 of 73 · 1,445 trades